Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sireesh Appajosyula"'
Publikováno v:
American Journal of Gastroenterology. 117:e1050-e1050
Publikováno v:
American Journal of Gastroenterology. 117:e1038-e1038
Publikováno v:
American Journal of Gastroenterology. 116:S1416-S1416
Publikováno v:
American Journal of Gastroenterology. 116:S629-S629
Autor:
Sachchidanand Tiwari, Harpal Singh, Neha Mehrotra, Surender Kharbanda, Bozena Korczak, Sireesh Appajosyula, Steve Laumas, Anees Mohammad
Publikováno v:
Cancer Research. 81:3107-3107
Small cell lung cancer (SCLC) is a highly malignant form of lung cancer that accounts for 15% of lung cancer cases. The tumor has a tendency to disseminate early resulting in ~ 85% patients being diagnosed with extensive stage disease (ES-SCLC). Chem
Autor:
Sachchidanand Tiwari, Bozena Korczak, Steve Laumas, Sireesh Appajosyula, Neha Mehrotra, Anees Mohammad, Harpal Singh, Surender Kharbanda
Publikováno v:
Cancer Research. 81:3082-3082
Triple negative breast cancer (TNBC) is an aggressive subtype with limited treatment options and a worse clinical outcome as compared with other breast cancer subtypes. Doxorubicin (DOX) is considered to be one of the most effective agents in the tre
Autor:
Harpal Singh, Surender Kharbanda, Sandeep Laumas, Anees Mohammad, Neha Mehrotra, Sachchidanand Tiwari, Sireesh Appajosyula
Publikováno v:
Journal of Clinical Oncology. 39:e15047-e15047
e15047 Background: Triple negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers and differ from other types of invasive breast cancers in that they grow and spread faster. TNBCs have limited treatment options and a worse progn
Autor:
Surender Kharbanda, Sireesh Appajosyula, Donald Kufe, Anees Mohammad, Harpal Singh, Mark R. Rosenberg, Sandeep Laumas, James H. Hill
Publikováno v:
Cancer Research. 80:491-491
Small cell lung cancer (SCLC) represents approximately 15% of all cases of lung cancer. SCLC patients have a poor prognosis and limited treatment options. Conventional chemotherapy can reduce the bulk of SCLC lesions, but cancer stem cells (CSCs) sur
Autor:
Donald Kufe, Sireesh Appajosyula, Sandeep Laumas, Surender Kharbanda, Anees Mohammad, Jugnu Jain, Bhawana Gupta, Harpal Singh
Publikováno v:
Cancer Research. 80:492-492
Triple-negative breast cancer (TNBC) accounts for approximately 15-20 % of all breast cancers, is an aggressive disease with a poor prognosis, and lacks targeted therapy. Recent studies suggest that cancer stem cells (CSCs) play an important role in
Publikováno v:
Advances in therapy. 35(4)
A large, statewide, fee-for-service Medicaid plan recently (October 2015) executed a complete switch from sublingual buprenorphine–naloxone [(SLBN), Suboxone®] to buccal buprenorphine–naloxone [(BBN), Bunavail®] on its preferred drug formulary.